DarioHealth Corp. (DRIO)
NASDAQ: DRIO · IEX Real-Time Price · USD
1.210
+0.040 (3.42%)
Jul 26, 2024, 4:30 PM EDT - Market closed
DarioHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 19.05 | 20.35 | 27.66 | 20.51 | 7.58 | 7.56 | Upgrade
|
| Revenue Growth (YoY) | -28.57% | -26.41% | 34.82% | 170.76% | 0.22% | 2.23% | Upgrade
|
| Cost of Revenue | 9.33 | 9.98 | 13.64 | 12.44 | 5.06 | 4.96 | Upgrade
|
| Gross Profit | 9.72 | 10.37 | 14.01 | 8.07 | 2.51 | 2.6 | Upgrade
|
| Selling, General & Admin | 45.03 | 41.8 | 46.82 | 62.36 | 27.98 | 16.61 | Upgrade
|
| Research & Development | 21.73 | 20.25 | 19.65 | 17.22 | 4.43 | 3.69 | Upgrade
|
| Depreciation & Amortization | 4.47 | 4.39 | 4.36 | 2.97 | - | - | Upgrade
|
| Operating Expenses | 71.22 | 66.43 | 70.82 | 82.54 | 32.42 | 20.3 | Upgrade
|
| Operating Income | -61.51 | -56.06 | -56.81 | -74.47 | -29.9 | -17.71 | Upgrade
|
| Interest Expense | -0.53 | -0.53 | -2.6 | - | - | - | Upgrade
|
| Interest & Investment Income | 1.92 | 1.87 | 0.51 | 0.04 | 0.06 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.24 | -0.21 | 0.24 | -0.2 | 0.45 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.75 | -4.34 | -3.53 | -0.08 | -0.05 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -55.6 | -59.27 | -62.19 | -74.71 | -29.45 | -17.74 | Upgrade
|
| Merger & Restructuring Charges | -0.13 | -0.13 | - | -2.02 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.02 | 0.04 | - | - | - | - | Upgrade
|
| Pretax Income | -55.71 | -59.36 | -62.19 | -76.73 | -29.45 | -17.74 | Upgrade
|
| Income Tax Expense | -1.93 | 0.06 | 0 | 0.03 | - | - | Upgrade
|
| Net Income | -53.78 | -59.43 | -62.19 | -76.76 | -29.45 | -17.74 | Upgrade
|
| Preferred Dividends & Other Adjustments | -4.43 | -4.57 | -2.24 | -9.24 | 3.66 | 3.16 | Upgrade
|
| Net Income to Common | -49.35 | -54.86 | -59.96 | -67.52 | -33.1 | -20.89 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 28 | 24 | 17 | 6 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 28 | 24 | 17 | 6 | 2 | Upgrade
|
| Shares Change (YoY) | 17.44% | 20.04% | 42.45% | 178.23% | 163.15% | 93.58% | Upgrade
|
| EPS (Basic) | -1.64 | -1.93 | -2.54 | -4.07 | -5.55 | -9.22 | Upgrade
|
| EPS (Diluted) | -1.64 | -1.93 | -2.54 | -4.07 | -5.55 | -9.22 | Upgrade
|
| Free Cash Flow | -39.3 | -30.96 | -48.29 | -50.67 | -17.85 | -15.82 | Upgrade
|
| Free Cash Flow Per Share | -1.31 | -1.09 | -2.04 | -3.05 | -2.99 | -6.98 | Upgrade
|
| Gross Margin | 51.02% | 50.95% | 50.67% | 39.34% | 33.17% | 34.36% | Upgrade
|
| Operating Margin | -322.96% | -275.46% | -205.42% | -363.06% | -394.71% | -234.22% | Upgrade
|
| Profit Margin | -282.37% | -292.00% | -224.88% | - | - | -234.63% | Upgrade
|
| Free Cash Flow Margin | -206.34% | -152.14% | -174.60% | -247.01% | -235.67% | -209.33% | Upgrade
|
| EBITDA | -56.41 | -51.08 | -52.09 | -70.02 | -29.71 | -17.52 | Upgrade
|
| EBITDA Margin | -296.17% | -250.96% | -188.36% | - | - | -231.80% | Upgrade
|
| D&A For EBITDA | 5.1 | 4.99 | 4.72 | 4.46 | 0.19 | 0.18 | Upgrade
|
| EBIT | -61.51 | -56.06 | -56.81 | -74.47 | -29.9 | -17.71 | Upgrade
|
| EBIT Margin | - | -275.46% | -205.42% | - | - | -234.22% | Upgrade
|
| Revenue as Reported | 19.04 | 20.35 | 27.66 | 20.51 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template.